ArticleFrontiers in bioengineering and biotechnology2026
An allosteric DNAzyme-Based modular system for dynamic computation and sensitive MicroRNA detection.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Circulating microRNAs (miRNAs) are widely studied as biomarkers for early diagnosis and disease follow-up, but their analysis is still limited by low abundance, short length, and high sequence similarity among miRNA family members. DNAzymes and entropy-driven catalysis (EDC) provide useful tools for nucleic acid sensing without exogenous protein enzymes. However, in many existing designs, signal amplification and molecular computation are treated as separate processes, and the amplified target signal is not readily converted into inputs for downstream logic circuits. To address this issue, we designed an allosterically regulated DNAzyme platform in which miRNA sensing and molecular computation are constructed from compatible nucleic acid modules. Methods: In the computing unit, controlled activation of DNAzymes was used to implement co-activated AND logic, thresholding, and subtraction. These gates were then connected through orthogonal sequence domains to form an integrated logic circuit capable of cascaded signal processing. In the sensing unit, an EDC reaction was coupled with DNAzyme-mediated cleavage to establish a self-feedback amplification pathway. First, the target miRNA initiates a strand displacement reaction to release an active DNAzyme. Subsequently, this DNAzyme cleaves its substrate to generate an initial fluorescence output and simultaneously release a secondary trigger for downstream signal amplification. Results: Using miRNA-10b as a model target, the biosensor operated under isothermal conditions without exogenous protein enzymes and showed a linear response from 50 pM to 5 nM, with a detection limit of 30 pM. The assay also distinguished miRNA-10b from single-base mismatched sequences and non-target miRNAs. Discussion: This work links EDC-based amplification with allosteric DNAzyme computation, offering a programmable strategy for nucleic acid systems that combine biomarker recognition with molecular information processing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.